JPSWY vs. CORT
JPSWY (Japan Steel Works Ltd ADR) and CORT (Corcept Therapeutics Incorporated) are both stocks. JPSWY operates in Specialty Industrial Machinery (Industrials), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, JPSWY returned 10.45%/yr vs 28.72%/yr for CORT. At a 0.05 correlation, their price movements are largely independent.
Performance
JPSWY vs. CORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JPSWY achieves a 0.58% return, which is significantly lower than CORT's 108.76% return. Over the past 10 years, JPSWY has underperformed CORT with an annualized return of 10.45%, while CORT has yielded a comparatively higher 28.72% annualized return.
JPSWY
- 1D
- 0.00%
- 1M
- -15.74%
- YTD
- 0.58%
- 6M
- -11.94%
- 1Y
- -7.06%
- 3Y*
- 33.26%
- 5Y*
- 12.15%
- 10Y*
- 10.45%
CORT
- 1D
- 2.04%
- 1M
- 40.79%
- YTD
- 108.76%
- 6M
- -13.17%
- 1Y
- 4.52%
- 3Y*
- 46.18%
- 5Y*
- 27.68%
- 10Y*
- 28.72%
JPSWY vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JPSWY Japan Steel Works Ltd ADR | 0.58% | 28.99% | 118.93% | -10.60% | -39.55% | 8.69% | 57.88% | 8.19% | -43.82% | 97.14% |
CORT Corcept Therapeutics Incorporated | 108.76% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
Correlation
The correlation between JPSWY and CORT is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.01 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2005 | 0.05 |
The correlation between JPSWY and CORT shifts across timeframes, from -0.06 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.
Fundamentals
JPSWY:
$3.68B
CORT:
$7.59B
JPSWY:
$132.50
CORT:
$0.41
JPSWY:
0.19
CORT:
177.15
JPSWY:
0.00
CORT:
88.25
JPSWY:
0.01
CORT:
10.96
JPSWY:
0.02
CORT:
11.89
JPSWY:
$278.58B
CORT:
$769.10M
JPSWY:
$65.14B
CORT:
$755.64M
JPSWY:
$30.68B
CORT:
$3.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JPSWY vs. CORT — Risk / Return Rank
JPSWY
CORT
JPSWY vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Japan Steel Works Ltd ADR (JPSWY) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JPSWY | CORT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.07 | 0.06 | -0.13 |
Sortino ratioReturn per unit of downside risk | 0.60 | 0.65 | -0.05 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.14 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 0.08 | 0.07 | +0.01 |
Martin ratioReturn relative to average drawdown | 0.16 | 0.13 | +0.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JPSWY | CORT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.07 | 0.06 | -0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.37 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.10 | 0.43 | -0.33 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.11 | -0.04 |
Drawdowns
JPSWY vs. CORT - Drawdown Comparison
The maximum JPSWY drawdown since its inception was -89.35%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for JPSWY and CORT.
Loading charts...
Drawdown Indicators
| JPSWY | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.35% | -94.28% | +4.93% |
Max Drawdown (1Y)Largest decline over 1 year | -41.31% | -64.40% | +23.09% |
Max Drawdown (3Y)Largest decline over 3 years | -41.34% | -71.85% | +30.51% |
Max Drawdown (5Y)Largest decline over 5 years | -56.56% | -71.85% | +15.29% |
Max Drawdown (10Y)Largest decline over 10 years | -86.74% | -71.85% | -14.89% |
Current DrawdownCurrent decline from peak | -43.88% | -36.39% | -7.49% |
Average DrawdownAverage peak-to-trough decline | -59.46% | -53.45% | -6.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.95% | 35.28% | -13.33% |
Volatility
JPSWY vs. CORT - Volatility Comparison
Japan Steel Works Ltd ADR (JPSWY) has a higher volatility of 23.11% compared to Corcept Therapeutics Incorporated (CORT) at 16.23%. This indicates that JPSWY's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JPSWY | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.11% | 16.23% | +6.88% |
Volatility (6M)Calculated over the trailing 6-month period | 63.38% | 85.05% | -21.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.10% | 76.53% | +20.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.80% | 74.50% | -7.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 102.76% | 67.20% | +35.56% |
Dividends
JPSWY vs. CORT - Dividend Comparison
Neither JPSWY nor CORT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JPSWY Japan Steel Works Ltd ADR | 0.00% | 0.66% | 0.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.35% | 11.31% | 1.06% |
Financials
JPSWY vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Japan Steel Works Ltd ADR and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JPSWY vs. CORT - Profitability Comparison
JPSWY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Japan Steel Works Ltd ADR reported a gross profit of 18.29B and revenue of 75.06B. Therefore, the gross margin over that period was 24.4%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
JPSWY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Japan Steel Works Ltd ADR reported an operating income of 7.92B and revenue of 75.06B, resulting in an operating margin of 10.6%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
JPSWY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Japan Steel Works Ltd ADR reported a net income of 4.38B and revenue of 75.06B, resulting in a net margin of 5.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
Frequently Asked Questions
JPSWY and CORT have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JPSWY has higher volatility (23.11%) compared to CORT (16.23%). In terms of maximum drawdown, JPSWY dropped -89.35% vs CORT's -94.28%.
CORT currently has the higher Sharpe Ratio (0.06 vs -0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JPSWY and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer